Activist investor Starboard has taken a $1 billion stake in Pfizer, according to a report, Rio Tinto approaches Arcadium ...
Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...
On top of this, Pfizer also faces key patent expirations of certain older products, and earlier estimated this will result in ...
Evan Seigerman, an analyst from BMO Capital, maintained the Buy rating on Pfizer (PFE – Research Report). The associated price target ...
U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Monday. Shares of Pfizer Inc PFE rose during ...
We recently compiled a list of the 8 Best Wide Moat Stocks to Buy According to Analysts. In this article, we are going to ...
Leerink Partners analyst David Risinger has maintained their neutral stance on PFE stock, giving a Hold rating yesterday. David Risinger has ...
Pfizer on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus ...
Verizon's strength stems from its dominant U.S. wireless market position, controlling approximately 40% of the postpaid phone ...
Pfizer ( PFE 3.18%) stock jumped 3.1% through 11:20 a.m. ET Monday morning in response to a Wall Street Journal article over ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback